CHA
JNJ icon

Carmichael Hill & Associates’s Johnson & Johnson JNJ Stock Holding History

Carmichael Hill & Associates’s Portfolio JNJ Stock Details JNJ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$3.35M Sell
20,646
-480
-2% -$76.5K 1.19% 19
2024
Q2 		$3.09M Sell
21,126
-318
-1% -$47.3K 1.21% 18
2024
Q1 		$3.39M Sell
21,444
-360
-2% -$57.3K 1.34% 16
2023
Q4 		$3.42M Sell
21,804
-557
-2% -$85.4K 1.42% 14
2023
Q3 		$3.48M Sell
22,361
-150
-0.7% -$24.8K 1.6% 11
2023
Q2 		$3.73M Buy
22,511
+42
+0.2% +$6.78K 1.67% 10
2023
Q1 		$3.48M Buy
22,469
+65
+0.3% +$10.5K 1.68% 10
2022
Q4 		$3.96M Sell
22,404
-577
-3% -$99.6K 2.03% 8
2022
Q3 		$3.75M Sell
22,981
-250
-1% -$42.3K 2.02% 8
2022
Q2 		$4.12M Sell
23,231
-440
-2% -$78.4K 2.17% 6
2022
Q1 		$4.2M Buy
23,671
+142
+0.6% +$24.2K 1.93% 6
2021
Q4 		$4.03M Sell
23,529
-272
-1% -$44.5K 1.81% 6
2021
Q3 		$3.84M Sell
23,801
-42
-0.2% -$7.17K 1.91% 6
2021
Q2 		$3.93M Sell
23,843
-15
-0.1% -$2.48K 1.99% 6
2021
Q1 		$3.92M Buy
23,858
+18
+0.1% +$2.91K 2.16% 6
2020
Q4 		$3.75M Buy
23,840
+36
+0.2% +$5.31K 2.21% 6
2020
Q3 		$3.54M Buy
23,804
+12
+0.1% +$1.78K 2.36% 6
2020
Q2 		$3.35M Sell
23,792
-680
-3% -$99.1K 2.46% 6
2020
Q1 		$3.21M Sell
24,472
-349
-1% -$49.5K 2.81% 5
2019
Q4 		$3.62M Sell
24,821
-105
-0.4% -$14.2K 2.57% 5
2019
Q3 		$3.23M Sell
24,926
-106
-0.4% -$14K 3.18% 5
2019
Q2 		$3.49M Sell
25,032
-247
-1% -$34.2K 3.46% 5
2019
Q1 		$3.53M Sell
25,279
-1,056
-4% -$141K 3.66% 5
2018
Q4 		$3.4M Sell
26,335
-1,044
-4% -$146K 3.87% 4
2018
Q3 		$3.78M Buy
27,379
+12
+0% +$1.59K 3.65% 4
2018
Q2 		$3.32M Buy
27,367
+4
+0% +$499 3.57% 4
2018
Q1 		$3.51M Sell
27,363
-458
-2% -$61.9K 3.83% 3
2017
Q4 		$3.89M Buy
+27,821
New +$3.88M 4.26% 3

Other funds holding JNJ

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Carmichael Hill & Associates's JNJ Position: Q3 2024 in Review

Carmichael Hill & Associates reduced its Johnson & Johnson (JNJ) stake by 2.3% in Q3 2024, selling an estimated $76.5K and leaving 20,646 shares worth $3.35M. The position accounts for 1.19% of the portfolio, ranked #19.

Carmichael Hill & Associates first reported a position in JNJ in Q4 2017 and has held it in 28 quarters since. The position peaked at $4.2M in Q1 2022. 3,881 funds tracked by Wall St. Rank hold JNJ as of Q3 2024.

  • Carmichael Hill & Associates held 20,646 shares of Johnson & Johnson worth $3.35M as of Q3 2024.
  • Carmichael Hill & Associates sold 480 Johnson & Johnson shares in Q3 2024, an estimated $76.5K.
  • Johnson & Johnson made up 1.19% of Carmichael Hill & Associates's portfolio in Q3 2024, its #19 holding.
  • Carmichael Hill & Associates first reported a position in Johnson & Johnson in Q4 2017 and has held it in 28 quarters since.
  • Carmichael Hill & Associates's Johnson & Johnson position peaked at $4.2M in Q1 2022.
  • 3,881 funds tracked by Wall St. Rank held Johnson & Johnson as of Q3 2024.

Based on Carmichael Hill & Associates's 13F filing for Q3 2024, filed 29 Oct 2024.